Phase 2/Phase 3 Program - Cumulative Safety & Tolerability (Completed Studies)

Phase 2/Phase 3 Program - Cumulative Safety & Tolerability (Completed Studies)

Overview of Adverse Events and Discontinuations

Format

PNG

Quelle:

Esperion Therapeutics, Inc.

Downloads